MHRA: Drug Safety Update (July 2021): COVID-19 vaccines: updates for July 2021

MHRA: Drug Safety Update (July 2021): Oral retinoid medicines (isotretinoin▼, alitretinoin▼, and acitretin▼): temporary monitoring advice during coronavirus (COVID-19) pandemic

MHRA: Drug Safety Update (July 2021): Herbal and homeopathic medicines: reminder to be vigilant for suspected adverse reactions and to report them to the Yellow Card scheme

MHRA: Drug Safety Update (July 2021): Chloramphenicol eye drops containing borax or boric acid buffers: use in children younger than 2 years

MHRA: Drug Safety Update (June 2021): COVID-19 vaccines: updates for June 2021

MHRA: Drup Safety Update (June 2021): Atezolizumab (Tecentriq▼) and other immune-stimulatory anti-cancer drugs: risk of severe cutaneous adverse reactions (SCARs)